Wang, W., Wu, L., Zhang, W., Lu, S., Fang, H., Yu, G., Zhou, M., Xing, W., Chen, Q., Li, X., Yang, N., Ye, M., Fang, W., Huang, Y., Liu, J., Tan, L., Hang, X., Zhang, W., Zhang, L., Chen, J., Zhang, X., Zhang, Y., Jiang, J., Zhong, A., Li, S., Liu, Y., Wu, G., Kang, X., Tian, Y., & Xu, T. (n.d.). 366 A randomized double-blind placebo-controlled phase III study evaluating perioperative toripalimab combined with platinum-based doublet chemotherapy in resectable stage III NSCLC. Journal for immunotherapy of cancer, 8, A391. http://access.bl.uk/ark:/81055/vdc_100144713637.0x000004